{"name":"Biotest Pharmaceuticals Corporation","slug":"biotest-pharmaceuticals-corporation","ticker":"","exchange":"","domain":"","description":"Biotest Pharmaceuticals Corporation is a biopharmaceutical company focused on the development and commercialization of plasma-derived therapies. The company has a pipeline of five drugs, with a strong focus on immunoglobulin products and treatments for various diseases.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Civacir® 10%","genericName":"Civacir® 10%","slug":"civacir-10","indication":"Prevention of hepatitis C virus reinfection in HCV-positive patients undergoing orthotopic liver transplantation","status":"phase_3"}]}],"pipeline":[{"name":"Civacir® 10%","genericName":"Civacir® 10%","slug":"civacir-10","phase":"phase_3","mechanism":"Civacir is a hepatitis C immunoglobulin (HCV-IG) that provides passive immunity by supplying antibodies against hepatitis C virus to prevent reinfection in transplant recipients.","indications":["Prevention of hepatitis C virus reinfection in HCV-positive patients undergoing orthotopic liver transplantation"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQYzZ1WkFVendNaW5NUzZvWGdla3MtaENFd2pfWGRSWFZlSGZad21kX1ZQZjdHQ2tZQldrQTBOX0hkcWZ4WnczZlhJQjJPOVlEaWRHSkZTRm5VS0VjSHdhM05rZE50SXJ6SHlWN0ZPLTdwZGw5Z2k1NVYtYXJBOVZjVVlrXzctaTBGYk1Z?oc=5","date":"2026-04-05","type":"pipeline","source":"IndexBox","summary":"Immunome CSO Sells Shares: Transaction Details & Company Snapshot - News and Statistics - IndexBox","headline":"Immunome CSO Sells Shares: Transaction Details & Company Snapshot - News and Statistics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOVzAwSTJpR2VkdXM3S21yc2FyaTBUTUpKOGxuc2xlaE8wUE5sT290MXZEekdFUnBCOENPSno0blZEYWRfUXpwbDhCT291QjlEWkNjMkU2QjlrY0NJaFVtbWUza3NzaWVRbzFJX0VPV1FCdXpWTE1RbVJ0RUFUT1d1SlBoTXE?oc=5","date":"2024-06-17","type":"regulatory","source":"Yahoo Finance","summary":"Biotest wins FDA approval for plasma protein therapy - Yahoo Finance","headline":"Biotest wins FDA approval for plasma protein therapy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNZHNjdkJLQ1FuOUNHeVpWa21ISVRQQm5uMUhZcHVsVDFzVmRUeWg1ZmVzTnBoeDR6NGhsSnh0dTcydTRQVnk4OXVfY1pTeGRlRmdpejRNNFZ4N3VKNUJQWFdfMXRTRmR6NHQzWGxRbTQwbDdlZTdtYmhZNUZYcFhaYjdQamszcmZFMVhnT2tCcWZqYVJPTDRlSTR0YlBsdw?oc=5","date":"2024-03-02","type":"pipeline","source":"BioProcess International","summary":"Establishing Single-Use Assemblies on Filling Equipment - BioProcess International","headline":"Establishing Single-Use Assemblies on Filling Equipment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPMlc0ck1VVTRMcld1MF9HNmxNM3JSZHlDT3NWbkVUUzNiMVBkeW1KTDRQSmJ2LVVER0R1VmFvNkNQSWQ1akpMZUpId2QtTUVjcVRRb18tZGhVVE9kQ0JOWjhNZXJlU0RyRHhkcm9KQUF6a2s5bjV3bldZUk01UlhKLTB3?oc=5","date":"2021-09-20","type":"deal","source":"Pharmaceutical Technology","summary":"Grifols agrees to acquire Tiancheng Pharmaceutical for $1.3bn - Pharmaceutical Technology","headline":"Grifols agrees to acquire Tiancheng Pharmaceutical for $1.3bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNX2tsN25iN2xYNTg5ZVoxYUJZVjlOY0xLOElqNXRkYnlJZGotS1VDZlNrOG1wYWZEc2FDWnh2V2lmNXhoSUFBUDdBUl84U3JRZXhHYm9yenBvZnZKc0FabWRvZ3BKa2M0eDUxQWtYeUVnYVJCVWtRSXNGeTZrbEpOMENjYmx2OWsyY0xCQjVaQy1WT0JnYU5DNTJJLVpPeGdUem96bzlRY2dfNXlwME9nWUFfWDV0TnJaeTNVYXBTY25xUQ?oc=5","date":"2021-09-17","type":"deal","source":"Reuters","summary":"Spain's Grifols to buy rival Biotest for up to $1.9 bln - Reuters","headline":"Spain's Grifols to buy rival Biotest for up to $1.9 bln","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPSzFQZkJzVVd1LThqVDNjdnBKU25iaU9nU3ZsSjdNSWZteENiQm1CeEEtbUc3YkpFeXZOZGZIMlVHTlZiNkszVkNzWmtxamxjT205MmhXdDhWZlB6MXoyNFhqNUQ4QlhHSHZJYTJvc3VBUHB5UklsMTdYTU5UM0Zha0tVNTQtSkFRdVBKVkF3NzJlTHRlZGFkUEhuUm95S2pFOERWY21nUnQ4Y0VMTTdNb1ppb1U?oc=5","date":"2021-09-17","type":"deal","source":"Bloomberg.com","summary":"Grifols Buys Biotest as Creat Pushed to Exit Blood-Plasma Stakes - Bloomberg.com","headline":"Grifols Buys Biotest as Creat Pushed to Exit Blood-Plasma Stakes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQZzd4VmZzMGhIYkVMRVlGcjRubkFpUDNrb2dIcjBHbktHT05vdzB0Y29XeGstS09zZ0NxQmV1MFgxNDFGSjE0N0I4WXJ2aEtHRFBuZlpwRGQyLVVFeWtoYUttRTg5cy1ZbzYwbmRRSlVBUnRMeXVyVUx4OTYxZzhwUWtieWZDNUYtYk1Uc0Q3QTZWYnp2TkVOUmdrR3lVUng2SUtRLVpicjgybkIxOHU4?oc=5","date":"2020-03-25","type":"pipeline","source":"Asset Publishing and Research","summary":"Tiancheng (Germany) Pharmaceutical Holdings completes takeover of Biotest - Asset Publishing and Research","headline":"Tiancheng (Germany) Pharmaceutical Holdings completes takeover of Biotest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxObVZxLW5paXQ0Z25hcTdxQWZiZWRKZ1lFakViMzJlSXBTbkhrZ1VFTEZ3aC15NmNacG1NdktUa2Z5dllFVndzbkRpSHZnSHk5NEMyalFXV0tzWTVSRDJsbm54VWcwVldkMnRiTXBCTXdQNXoweThhYWpYODFlLXkyQWo3dHFuUlp6MUphd2VKaV9xWlRSdV9zSnFrTXFBbGZ0RWtvTGtvWjFyRGFWZFlNVy1zbzNYcm5ydW1J?oc=5","date":"2019-05-13","type":"pipeline","source":"Fierce Pharma","summary":"ADMA Biologics returning Bivigam to market after 3-year absence - Fierce Pharma","headline":"ADMA Biologics returning Bivigam to market after 3-year absence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPVk1BaGk4b01ycW43NXQ4NV82UXNrSmNTbUN0WHRlOXIyWEhBU01qU1FoWENuUXpfSExnNTNLbFF4T3pzYjR4TGVzT090RjA1NUw4blZXYW5UTXkyNlh6d1FjMUVzbzc0N185Tm1za3luVWpzUm14M2JnckllVXJUUkthbEZ1TXU3OHZremNnT2RXVmcw?oc=5","date":"2019-05-09","type":"pipeline","source":"Georgia Health News","summary":"Blood products: Plasma business thriving in Georgia - Georgia Health News","headline":"Blood products: Plasma business thriving in Georgia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOVk9uMS1OR3ZzVm9KZzJ5WjBNMUdLTlJOZ0pGMnE0VFhVaEFtVGU2aWZzZk5qdjlHSWNrall1Sjl6Y3NkYVNsZWpIRHNzaS05aU9jNE1rb0NLb2s0NW10YlY4ckpPZWRQZzNKRzlNNU5SWUdLNUYwRUgtYU9PcXpGZllMeFc1X2taNzJsbjlCQUp0cHc3UGhMRXFwSl8yT1NVVjRmQnk2MzIwZFV4SGh5d2Jtaw?oc=5","date":"2018-08-02","type":"deal","source":"The Pharma Letter","summary":"Grifols acquires Biotest, expanding catalog of plasma donation centers - The Pharma Letter","headline":"Grifols acquires Biotest, expanding catalog of plasma donation centers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNRlBfVWRIZlF0akxxaUZ4cFUzeFJ1VTVFWlQyUnNBY1c3Y0t5VVZBUHB3akdSaWk1R0JpQXlhbWJtb2EwbmE2dWRyZndwWEJXdDJEdFdTU2hOWWZHTzlWVjNaQzQzMGJ4TXZXNFF3bHdqWUlDRGZETFc5M0QyT2hTVzRXZl9lb2stZHNqOWdvRDAyVTZBNFFCbA?oc=5","date":"2018-08-02","type":"pipeline","source":"BioPharma Dive","summary":"Success for ADMA as Bivigam inspection file closes - BioPharma Dive","headline":"Success for ADMA as Bivigam inspection file closes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNakUyVzRleGk2cXdSMHpuSjRLQ3BDNVdUQS1RX2lXTEU1Ym4zaE5TMTJIZ0FUVXBZQ3htVjBCVHpwMlJoVmJtejZ5R05teDR4MkV1amp2WHlFOVpOSHBsVEdzOG9CTkk0Yl9YVGhzak01VnpfeTRhRzBZSEJGeDZ4TTVIU3Z5dw?oc=5","date":"2007-09-12","type":"deal","source":"Contract Pharma","summary":"Biotest To Buy Nabi Biologics Biz - Contract Pharma","headline":"Biotest To Buy Nabi Biologics Biz","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}